- Home
- Publications
- Publication Search
- Publication Details
Title
New treatments for the motor symptoms of Parkinson’s disease
Authors
Keywords
-
Journal
Expert Review of Clinical Pharmacology
Volume 7, Issue 6, Pages 761-777
Publisher
Informa UK Limited
Online
2014-10-16
DOI
10.1586/17512433.2014.966812
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adenosine A2A Receptor Antagonists in Parkinson’s Disease: Progress in Clinical Trials from the Newly Approved Istradefylline to Drugs in Early Development and Those Already Discontinued
- (2014) Annalisa Pinna CNS DRUGS
- Long-Acting Versus Standard Non-Ergot Dopamine Agonists in Parkinson's Disease: A Meta-Analysis of Randomized Controlled Trials
- (2014) Chang-Qing Zhou et al. CNS Neuroscience & Therapeutics
- Two new adenosine receptor antagonists for the treatment of Parkinson's disease: istradefylline versus tozadenant
- (2014) Santiago Perez-Lloret et al. EXPERT OPINION ON PHARMACOTHERAPY
- Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patients
- (2014) Marios Politis et al. JOURNAL OF CLINICAL INVESTIGATION
- Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial
- (2014) Robert A Hauser et al. LANCET NEUROLOGY
- Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease
- (2014) Rupam Borgohain et al. MOVEMENT DISORDERS
- Effect of nicotine on l-dopa-induced dyskinesia in animal models of Parkinson’s disease: a systematic review and meta-analysis
- (2014) Cheng-long Xie et al. NEUROLOGICAL SCIENCES
- Randomized clinical trial of topiramate for levodopa-induced dyskinesia in Parkinson's disease
- (2014) Christopher Kobylecki et al. PARKINSONISM & RELATED DISORDERS
- Symptomatic efficacy of rasagiline monotherapy in early Parkinson's disease: Post-hoc analyses from the ADAGIO trial
- (2014) Joseph Jankovic et al. PARKINSONISM & RELATED DISORDERS
- Chronic monoamine oxidase-B inhibitor treatment blocks monoamine oxidase-A enzyme activity
- (2013) Jasmin Bartl et al. JOURNAL OF NEURAL TRANSMISSION
- Efficacy and safety of opicapone, a new COMT-inhibitor, for the treatment of motor fluctuations in Parkinson's Disease patients: BIPARK-II study
- (2013) A. Lees et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial
- (2013) Robert A Hauser et al. LANCET NEUROLOGY
- Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
- (2013) C Warren Olanow et al. LANCET NEUROLOGY
- Progressive ataxia associated with scarring skin lesions and vertical gaze palsy
- (2013) Christos Ganos et al. MOVEMENT DISORDERS
- Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease
- (2013) Peter A. LeWitt et al. MOVEMENT DISORDERS
- Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations
- (2013) Rupam Borgohain et al. MOVEMENT DISORDERS
- Adenosine A2Areceptor antagonist istradefylline reduces daily OFF time in Parkinson's disease
- (2013) Yoshikuni Mizuno et al. MOVEMENT DISORDERS
- AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study
- (2013) Fabrizio Stocchi et al. MOVEMENT DISORDERS
- Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease
- (2013) C. Warren Olanow et al. MOVEMENT DISORDERS
- Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson's disease
- (2013) Maryka Quik et al. MOVEMENT DISORDERS
- Withdrawing amantadine in dyskinetic patients with Parkinson disease: The AMANDYSK trial
- (2013) F. Ory-Magne et al. NEUROLOGY
- Brain and peripheral pharmacokinetics of levodopa in the cynomolgus monkey following administration of opicapone, a third generation nitrocatechol COMT inhibitor
- (2013) M.J. Bonifácio et al. NEUROPHARMACOLOGY
- Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens
- (2013) F. Mancini et al. PARKINSONISM & RELATED DISORDERS
- Neuropathy in Parkinson’s Disease Patients with Intestinal Levodopa Infusion versus Oral Drugs
- (2013) Constanze Jugel et al. PLoS One
- Perampanel in Parkinson Disease Fluctuations
- (2012) Olivier Rascol et al. CLINICAL NEUROPHARMACOLOGY
- Actively Transported Levodopa Prodrug XP21279
- (2012) Peter A. LeWitt et al. CLINICAL NEUROPHARMACOLOGY
- Targeting Glutamate Receptors to Tackle the Pathogenesis, Clinical Symptoms and Levodopa-Induced Dyskinesia Associated with Parkinson’s Disease
- (2012) Susan Duty CNS DRUGS
- Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease
- (2012) A. H. V. Schapira et al. EUROPEAN JOURNAL OF NEUROLOGY
- Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study
- (2012) C. Moreau et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Istradefylline, an adenosine A2A receptor antagonist, for patients with Parkinson's Disease: A meta-analysis
- (2012) Wanqiang Chen et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial
- (2012) Caroline Moreau et al. LANCET NEUROLOGY
- L-threo-3,4-dihydroxyphenylserine (L-DOPS) co-administered with entacapone improves freezing of gait in Parkinson’s disease
- (2012) Kei Fukada et al. MEDICAL HYPOTHESES
- A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3
- (2012) T. A. Zesiewicz et al. NEUROLOGY
- Randomized clinical trial of fipamezole for dyskinesia in Parkinson disease (FJORD study)
- (2012) P. A. LeWitt et al. NEUROLOGY
- Pardoprunox as adjunct therapy to levodopa in patients with Parkinson’s disease experiencing motor fluctuations: Results of a double-blind, randomized, placebo-controlled, trial
- (2012) O. Rascol et al. PARKINSONISM & RELATED DISORDERS
- Future Treatments for Parkinson's Disease: Surfing the PD Pipeline
- (2011) Robert A. Hauser INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Perampanel, an AMPA antagonist, found to have no benefit in reducing “off” time in Parkinson's disease
- (2011) Andrew Lees et al. MOVEMENT DISORDERS
- A randomized, double-blind, placebo-controlled trial of levetiracetam for dyskinesia in Parkinson's disease
- (2011) Kitty K. Wong et al. MOVEMENT DISORDERS
- A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients
- (2011) Fabrizio Stocchi et al. MOVEMENT DISORDERS
- AFQ056 treatment of levodopa-induced dyskinesias: Results of 2 randomized controlled trials
- (2011) Daniela Berg et al. MOVEMENT DISORDERS
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
- (2011) Susan H. Fox et al. MOVEMENT DISORDERS
- Methylphenidate for gait impairment in Parkinson disease: A randomized clinical trial
- (2011) A. J. Espay et al. NEUROLOGY
- Levetiracetam for levodopa-induced dyskinesia in Parkinson’s disease: a randomized, double-blind, placebo-controlled trial
- (2010) Martin Wolz et al. JOURNAL OF NEURAL TRANSMISSION
- Levetiracetam for the management of levodopa-induced dyskinesias in Parkinson's disease
- (2010) P. Stathis et al. MOVEMENT DISORDERS
- Assessment of MAO-B Occupancy in the Brain With PET and [11C]-L-Deprenyl-D2: A Dose-Finding Study With a Novel MAO-B Inhibitor, EVT 301
- (2009) J Hirvonen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The dopaminergic stabilizers pridopidine (ACR16) and (−)-OSU6162 display dopamine D2 receptor antagonism and fast receptor dissociation properties
- (2009) Tino Dyhring et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Istradefylline as monotherapy for Parkinson disease: Results of the 6002-US-051 trial
- (2009) H.H. Fernandez et al. PARKINSONISM & RELATED DISORDERS
- The dopaminergic stabilizer ASP2314/ACR16 selectively interacts with D2Highreceptors
- (2009) Philip Seeman et al. SYNAPSE
- Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia
- (2008) A. Munoz et al. BRAIN
- Effects of (−)-OSU6162 and ACR16 on motor activity in rats, indicating a unique mechanism of dopaminergic stabilization
- (2008) Johan P. Rung et al. JOURNAL OF NEURAL TRANSMISSION
- Pharmacokinetics and pharmacodynamics of levodopa
- (2008) John G. Nutt MOVEMENT DISORDERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started